Image
Joe Watabe, MS
CFAR Developmental Core Manager
This program is currently on indefinite hold due to changing NIH policies.
Amount available: $30,000 in direct costs for 1 year
Apply through the UCSF Resource Allocation Program (RAP) portal
The International Mentored Scientist Award seeks to provide a mentored career development opportunity in HIV research for international investigators affiliated with UCSF. Applicants for this award must indicate a UCSF-affiliated faculty research mentor(s) in HIV who will commit to guiding the applicant for the application process and throughout the duration of the proposed project. Project proposals should be geared toward the interests of the applicant (e.g., clinical, basic, implementation science and/or behavioral-epidemiological research) and focus on HIV research in the investigator’s home country.
Eligibility
Researchers (all levels), post-doctoral fellows, and trainees located at a UCSF-affiliated foreign institution who have not received an NIH R01- equivalent grant in HIV/AIDS are eligible. Please note that CFAR is not allowed to provide funding to any investigators who have received HIV-related R01 awards. More senior faculty members may apply only if they are newly entering the field of HIV research.
Designation of Mentor (Critical)
Mentoring is critical to the training component of the CFAR International Mentored Scientist awards. All International Mentored award applications require a faculty research mentor from UCSF or a UCSF-affiliated institution (https://cfar.ucsf.edu/about/partners). Applications without a mentor will be disqualified.
Applicants must identify their UCSF-affiliated mentors and arrange to receive mentor advice and guidance on the research portion of their application well before it is submitted (typically at least two months before the RAP deadline). CFAR is no longer available to assist with mentor identification.
Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.
CFAR requests that applicants review the NIAID HIV Language Guide as they prepare their proposals so that they can follow best practices on language for communicating respectfully about HIV and related topics, including the use of person-first, non-stigmatizing language. Please contact us if you have any questions about this request.
The award amount is $30,000 in direct costs for one year.
For more detailed information about this RFA, please see the RAP Portal.
International Mentored Science Awardees
38 Awards
-
Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth
Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth
Abstract
The Vδ2+ subset of γδ T cells possess intrinsic reactivity to malaria antigens and may be an important antimalarial effector mechanism, but there is evidence that chronic exposure to malaria and HIV is associated with the loss and dysfunction of this subset. It is unclear whether in utero exposure to malaria or HIV is associated with reduced frequencies and/or dysfunction of Vδ 2+ T cells.
-
Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth
Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth
Abstract
The Vδ2+ subset of γδ T cells possess intrinsic reactivity to malaria antigens and may be an important antimalarial effector mechanism, but there is evidence that chronic exposure to malaria and HIV is associated with the loss and dysfunction of this subset. It is unclear whether in utero exposure to malaria or HIV is associated with reduced frequencies and/or dysfunction of Vδ 2+ T cells.
-
Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa
Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa
Abstract
Depression is a serious public health concern, due to its negative impact of women's health, their infants and their families. HIV-infected caregivers are at high risk for a range of psychiatric and emotional problems that impact medication adherence and disease progression, and negatively affect mother-infant interactions, infant and child health, and development outcomes.
-
Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa
Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa
Abstract
Depression is a serious public health concern, due to its negative impact of women's health, their infants and their families. HIV-infected caregivers are at high risk for a range of psychiatric and emotional problems that impact medication adherence and disease progression, and negatively affect mother-infant interactions, infant and child health, and development outcomes.